1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of ...

Novartis announced it will spend $23 billion to construct and expand facilities in the United States. The planned investment includes six new manufacturing plants, including two radioligand therapy ...

Bengaluru, India–based Biocon Biologics announced today that bevacizumab-nwgd (Jobevne), a biosimilar of bevacizumab (Avastin; Genentech), was approved by the FDA. Bevacizumab, which is given ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Gretchen M. Alicea; Payal Patel; Marie E. Portuallo; Mitchell E. Fane; Meihan Wei; Yash Chhabra; Agrani Dixit; Alexis E. Carey; Vania Wang; Murilo R. Rocha; Reeti ...

1Department of Urology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China. 2Department of Urology, Shanghai Changzheng Hospital, Naval Medical ...

Department of Anatomy and Cell biology, Rush University Medical Center, Chicago, Illinois.

1Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.

Marc Michel; Maryam Heidary; Anissa Mechri; Kévin Da Silva; Marine Gorse; Victoria Dixon; Klaus von Grafenstein; Charline Bianchi; Caroline Hego; Aurore Rampanou ...

David Fandrei; Sabine Seiffert; Michael Rade; Susanne Rieprecht; Nico Gagelmann; Patrick Born; Thomas Wiemers; Heike Weidner; Markus Kreuz; Tamara Schassberger ...

1Biomarkers and Clonal Dynamics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain.

Copyright held by the owner/author(s).